SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT

替加宾盐酸盐作为辅助治疗的安全性和有效性

• 批准号: 6274869
• 负责人: GREGORY Y CHANG
• 金额: $ 3.67万
• 依托单位: UNIVERSITY OF SOUTHERN CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6274869
• 关键词: anticonvulsants; carbamazepine; clinical research; combination chemotherapy; drug screening /evaluation; human subject; human therapy evaluation; nervous system disorder chemotherapy; neurotransmitter transport; partial seizure; phenytoin; transport inhibitor

The primary objective of this study is to compare the safety and efficacy of tiagabine HCL with carbamazepine and phenytoin when administered as the first add-on treatment for patients with complex partial seizures with or without secondary generalization incompletely controlled with carbamazepine or phenytoin monotherapy.

这项研究的主要目的是比较其安全性和有效性。 盐酸硫加宾与卡马西平和苯妥英钠合用 复杂部分性癫痫伴或合并癫痫患者的首次附加治疗 没有二次泛化的情况下不完全控制 卡马西平或苯妥英单用。